Cost-utility of Intravenous Immunoglobulin (IVIG) compared with corticosteroids for the treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in Canada

OBJECTIVES: Intravenous immunoglobulin (IVIG) has demonstrated improvement in chronic inflammatory demyelinating polyneuropathy (CIDP) patients in placebo controlled trials. However, IVIG is also much more expensive than alternative treatments such as corticosteroids. The objective of the paper is t...

Descripción completa

Detalles Bibliográficos
Autores principales: Blackhouse, Gord, Gaebel, Kathryn, Xie, Feng, Campbell, Kaitryn, Assasi, Nazila, Tarride, Jean-Eric, O'Reilly, Daria, Chalk, Colin, Levine, Mitchell, Goeree, Ron
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2903512/
https://www.ncbi.nlm.nih.gov/pubmed/20565778
http://dx.doi.org/10.1186/1478-7547-8-14

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2903512/
https://www.ncbi.nlm.nih.gov/pubmed/20565778
http://dx.doi.org/10.1186/1478-7547-8-14

Ejemplares similares